A Chinese study by Wang et al. in 2019 concluded that VD3 may play a role in the manifestation of GDM by controlling the development of adipocytes through VD3 receptors and peroxisome proliferator-activated receptor γ (PPARγ) pathways [30]. This evidence concerns the gene PPARG and gestational diabetes.